Skip to main content
Premium Trial:

Request an Annual Quote

Illumina s Q4 Revenues Surge on Strong Sales, Net Losses Narrow

NEW YORK, Jan. 27 (GenomeWeb News) - Illumina today reported a 176 percent increase in revenues for its fourth fiscal quarter, accompanied by diminishing net losses and a slight decrease in R&D spending.

For the quarter ended Dec. 28, 2003, Illumina reported revenue of $10.7 million, compared to $3.9 million for the fourth quarter of 2002.

The company attributed the revenue increase to the sale of two SNP-genotyping BeadLab systems during the quarter, as well as strong sales in its system consumables, genotyping services, and oligo product lines. The company said it also saw the first revenues from its newly launched gene-expression offering during the quarter.

Illumina's net loss for the quarter was $4.0 million, or $0.12 per share, compared to a net loss of $7.6 million, or $0.24 per share, in the year-ago period.

The company spent $5.5 million on R&D in the fourth quarter of 2003, down from $6.3 million in the same period of 2002.

As of Dec. 28, 2003, Illumina's cash, investments, and long-term restricted investments totaled $45.1 million. Cash and investments alone totaled $32.9 million.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.